Sana Biotechnology Inc (SANA) — Financial Flexibility Index
Sana Biotechnology Inc (SANA) has a Financial Flexibility Index of -0.15x as of March 2026. Free cash flow of $-37.09 Million (operating CF $-37.38 Million minus capex $288.00K) represents 0% of total liabilities ($254.35 Million). Check SANA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sana Biotechnology Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Sana Biotechnology Inc across 8 annual periods. See Sana Biotechnology Inc (SANA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sana Biotechnology Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Sana Biotechnology Inc. For the full company profile including market capitalisation, see Sana Biotechnology Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-142.89 Million | $-143.83 Million | $256.01 Million | ▲ +26.3% |
| 2024 | -0.76x | $-189.72 Million | $-223.15 Million | $250.52 Million | ▲ +9.9% |
| 2023 | -0.84x | $-233.55 Million | $-253.58 Million | $277.79 Million | ▼ -1.0% |
| 2022 | -0.83x | $-269.17 Million | $-290.05 Million | $323.40 Million | ▼ -50.9% |
| 2021 | -0.55x | $-221.19 Million | $-251.05 Million | $400.90 Million | ▼ -456.8% |
| 2020 | -0.10x | $-114.11 Million | $-137.98 Million | $1.15 Billion | ▲ +6.8% |
| 2019 | -0.11x | $-59.32 Million | $-85.50 Million | $557.73 Million | ▲ +61.2% |
| 2018 | -0.27x | $-13.04 Million | $-13.49 Million | $47.52 Million | — |